U.S. markets closed
  • S&P Futures

    4,567.00
    -8.75 (-0.19%)
     
  • Dow Futures

    34,583.00
    -39.00 (-0.11%)
     
  • Nasdaq Futures

    15,946.25
    -42.25 (-0.26%)
     
  • Russell 2000 Futures

    2,196.50
    -8.70 (-0.39%)
     
  • Crude Oil

    66.82
    +0.32 (+0.48%)
     
  • Gold

    1,769.30
    +6.60 (+0.37%)
     
  • Silver

    22.36
    +0.04 (+0.20%)
     
  • EUR/USD

    1.1298
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3290
    -0.0012 (-0.09%)
     
  • USD/JPY

    113.1590
    -0.0500 (-0.04%)
     
  • BTC-USD

    56,671.94
    -359.91 (-0.63%)
     
  • CMC Crypto 200

    1,443.64
    +4.76 (+0.33%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,792.94
    +39.57 (+0.14%)
     

SHAREHOLDER ALERT: ROOT CS EBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 16, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Root, Inc (NASDAQ:ROOT)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/root-inc-loss-submission-form?prid=15907&wire=1
Lead Plaintiff Deadline: May 18, 2021
This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Root Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about October 28, 2020.

Allegations against ROOT include that: (i) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (ii) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (iii) notwithstanding the Defendants' touting of Root's purportedly unique, data-driven advantages, several of the Company's established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (iv) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Credit Suisse Group AG (NYSE:CS)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/credit-suisse-group-ag-loss-submission-form?prid=15907&wire=1
Lead Plaintiff Deadline: June 15, 2021
Class Period: October 29, 2020 - March 31, 2021

Allegations against CS include that: defendants concealed material defects in the Company's risk policies and procedures and compliance oversight functions and efforts to allow high-risk clients to take on excessive leverage, including Greensill Capital ("Greensill") and Archegos Capital Management ("Archegos"), exposing the Company to billions of dollars in losses.

Emergent Biosolutions Inc. (NYSE:EBS)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/emergent-biosolutions-inc-loss-submission-form?prid=15907&wire=1
Lead Plaintiff Deadline: June 18, 2021
Class Period: July 6, 2020 - March 31, 2021

Allegations against EBS include that: (i) Emergent's Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (ii) these longstanding contamination risks and quality control issues at Emergent's facility led to a string of FDA citations; (iii) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, Defendants' public statements about Emergent's ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/647644/SHAREHOLDER-ALERT-ROOT-CS-EBS-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines